BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3986797)

  • 1. Mechanism of mouse skin tumor promotion by chrysarobin.
    DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
    Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents.
    DiGiovanni J; Walker SC; Beltran L; Naito M; Eastin WC
    Cancer Res; 1991 Mar; 51(5):1398-405. PubMed ID: 1900038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones.
    DiGiovanni J; Kruszewski FH; Coombs MM; Bhatt TS; Pezeshk A
    Carcinogenesis; 1988 Aug; 9(8):1437-43. PubMed ID: 3402040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
    Bhasin G; Kauser H; Athar M
    Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in epidermal polyamine levels and DNA synthesis following topical treatment with chrysarobin in SENCAR mice.
    Kruszewski FH; DiGiovanni J
    Cancer Res; 1988 Nov; 48(22):6390-5. PubMed ID: 3180057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of chrysarobin skin tumor promotion.
    DiGiovanni J; Kruszewski FH; Chenicek KJ
    Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice.
    DiGiovanni J; Boutwell RK
    Carcinogenesis; 1983; 4(3):281-4. PubMed ID: 6831635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants.
    Battalora MS; Kruszewski FH; DiGiovanni J
    Carcinogenesis; 1993 Dec; 14(12):2507-12. PubMed ID: 8269619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic alterations produced by chrysarobin (1,8-dihydroxy-3-methyl-9-anthrone) in SENCAR mouse skin: relationship to skin tumor promoting activity.
    Kruszewski FH; Naito M; Naito Y; DiGiovanni J
    J Invest Dermatol; 1989 Jan; 92(1):64-71. PubMed ID: 2462598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of calcium antagonists on anthrone skin tumor promotion and promoter-related effects in SENCAR mice.
    Battalora MS; Johnston DA; DiGiovanni J
    Cancer Lett; 1995 Nov; 98(1):19-25. PubMed ID: 8529201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
    Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
    Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: association with epidermal hyperplasia and tumor promotion.
    Hansen LA; Monteiro-Riviere NA; Smart RC
    Cancer Res; 1990 Sep; 50(18):5740-5. PubMed ID: 2393848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
    Verma AK
    Cancer Res; 1988 Apr; 48(7):1736-9. PubMed ID: 3127039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.
    Lahiri-Chatterjee M; Katiyar SK; Mohan RR; Agarwal R
    Cancer Res; 1999 Feb; 59(3):622-32. PubMed ID: 9973210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic factors controlling responsiveness to skin tumor promotion in mice.
    DiGiovanni J
    Prog Clin Biol Res; 1995; 391():195-212. PubMed ID: 8532717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.